Log In
BCIQ
Print this Print this
 

Asonep (Sphingomab (humanized))

  Manage Alerts
Collapse Summary General Information
Company Lpath Inc.
DescriptionSystemic formulation of a humanized mAb against sphingosine 1-phosphate (S1P)
Molecular Target Sphingosine 1-phosphate (S1P)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$511.0M

0

$497.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/20/2010

$511.0M

0

$497.5M

Get a free BioCentury trial today